(Q43737841)

26 November 2017

Effects of alosetron on spontaneous migrating motor complexes in murine small and large bowel in vitro (English)

1 reference

26 November 2017

1 reference

4

Sanders KM

0 references

Terence K. Smith

5

object named as

Smith TK

0 references

author name string

Bush TG

1

1 reference

26 November 2017

Spencer NJ

2

1 reference

26 November 2017

Watters N

3

1 reference

26 November 2017

1 October 2001

1 reference

American Journal of Physiology - Gastrointestinal and Liver Physiology

26 November 2017

1 reference

26 November 2017

281

1 reference

26 November 2017

4

1 reference

26 November 2017

G974-83

1 reference

Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study

26 November 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

Pharmacological differences and similarities between the native mouse 5-HT3 receptor in N1E-115 cells and a cloned short splice variant of the mouse 5-HT3 receptor expressed in HEK 293 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

Spontaneous migrating motor complexes occur in both the terminal ileum and colon of the C57BL/6 mouse in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

The pharmacological characterization of 5-HT3 receptors in three isolated preparations derived from guinea-pig tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

Review article: irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

The pharmacological properties of the novel selective 5-HT3 receptor antagonist, alosetron, and its effects on normal and perturbed small intestinal transit in the fasted rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

Anxiolytic potential of 5-HT3 receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

Review article: an integrated approach to the irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

Irritable bowel syndrome in office-based practice in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

Colonic migrating motor complexes (CMMCs) in the isolated mouse colon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

Modulation by 5-HT3 and 5-HT4 receptors of the release of 5-hydroxytryptamine from the guinea-pig small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting. A comparison of their pharmacology and clinical efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

Review article: clinical pharmacology of alosetron

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

Dysmotility of the small intestine in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

The properties of 5-HT3 receptors in clonal cell lines studied by patch-clamp techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

Towards positive diagnosis of the irritable bowel

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

Review article: gender-related differences in functional gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

Role of visceral afferent mechanisms in functional bowel disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

Medium-term effects of a new 5HT3 antagonist, alosetron, in patients with carcinoid diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

GR 38032F (ondansetron), a selective 5HT3 receptor antagonist, slows colonic transit in healthy man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

Irritable bowel syndrome defined by factor analysis. Gender and race comparisons

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

Motor dysfunction of the small bowel and colon in patients with the carcinoid syndrome and diarrhea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

5-HT3 receptors mediate rapid responses in cultured hippocampus and a clonal cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

10.1152/AJPGI.2001.281.4.G974

21 January 2018

Identifiers

DOI

0 references

1 reference